Meeting Summary: The Florida Gastroenterologic Society's Annual Meeting is the leading event for GI professionals in the state of Florida. FGS is joined with members of the SGNA to enhance the full spectrum of individuals working in the gastroenterology field. The introduction and advances of innovative diagnostic techniques and novel therapeutics has created an exciting range of approaches to many important areas of GI disease and patient care. The Florida Gastroenterologic Society has a long history of providing advanced continuing medical education to its members. Following this tradition, we are planning our 2018 Annual Meeting to meet the growing educational challenges that practicing Gastroenterologist are facing today. The main objective of this course will be to update current clinical knowledge and processes to optimize clinical care for patients.
The topics covered in this activity will be those oftentimes seen in everyday gastroenterology and hepatology practice, but will focus on specific advancements over the recent past which will provide cutting edge knowledge regarding approach and treatment to these conditions. There will be emphasis on a guideline-directed approach as well as an emphasis on pharmacotherapeutics in the management of common gastrointestinal disorders. These will include both hollow organ digestive diseases as well as solid organ disorders of the liver and pancreas. We will explore the role of endoscopy in a subset of disorders, carefully evaluating both the cost-benefit ratio as well as the risk-benefit ratio, and look into future endoscopic / minimally invasive approaches to the management of GI patients. There will be a special Hands-on Endoscopy Workshop to allow participants to learn on a more individual basis the performance of special endoscopic procedures by expert endoscopists. Furthermore, a special session is dedicated to quality performance in GI, both in the performance of colonoscopy and in the maintenance of electronic health records.
The program is designed for gastroenterologists, gastroenterology trainees, primary care physicians, nurses, physician assistants and nurse practitioners interested in the latest information on diagnostic GI and state of the art treatment of these illnesses.
Hotel Information: Special room rates have been established at the Hyatt Regency Grand Cypress. RESERVATIONS MUST BE MADE BEFORE AUGUST 23, 2018 to ensure you receive the discounted rate of $189.00 / night. To make your reservation, please contact the Hyatt Regency Grand Cypress Resort at 1-407 239 1234 or book your reservation online at:
Accreditation / CME / MOC: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Florida Medical Association and
the Florida Gastroenterologic Society. The Florida Medical Association is accredited by the ACCME to provide continuing medical education for physicians.
The Florida Medical Association designates this live activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes
participation in the evaluation component enables the participant to earn up to 8.5 MOC points in the American Board of internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to the ACCME for the purpose of granting ABIM MOC credit.
Educational Objectives: Upon completion of this course, participants should be able to:
· Recognize the latest guidelines for screening and surveillance of colorectal cancer and polyps
· Understand the epidemiology and pathophysiology of interval cancers and the impact on clinical guidelines
· Recognize the latest guidelines for screening and surveillance of Barrett’s esophagus
· Understand the role of radiofrequency ablation for Barrett’s esophagus and post-ablative surveillance
· Recognize the latest guidelines in the approach to acute non-variceal bleeding
· Understand the optimal timing of endoscopy and pharmacotherapies in the management of gastrointestinal bleeding
· Understand the newest therapeutic modalities for treatment of gastrointestinal bleeding
· Recognize the latest guidelines in the approach to pancreatic cystic lesions
· Understand the latest biochemical and molecular methods to differentiate pre-malignant from non-malignant pancreatic cystic lesions
· Recognize the importance of quality metrics in colorectal cancer screening and surveillance
· Understand methods for improvement of quality metrics in colorectal cancer screening and surveillance.
· Recognize the emerging importance of quality measures of electronic medical notes
· Understand the impact of electronic medical notes on reimbursement and fraud audits
· Recognize the role of endoscopy in the management of eosinophilic esophagitis
· Understand the short-term and long-term medical therapies for eosinophilic esophagitis
· Recognize the increased need for alternative minimally invasive therapies for GERD
· Understand the risks and benefits and long-term outcomes of endoscopic therapies for GERD
· Recognize the significance of microscopic and collagenous colitis and how it differs from inflammatory bowel disease
· Understand the management approach to microscopic/collagenous colitis
· Recognize the approach to severe necrotizing pancreatitis
· Understand the indications and therapeutic methods for draining pancreatic fluid collections
· Provide a comprehensive review of the adverse events associated with proton pump inhibitors
· Understand a strategy for withdrawing proton pump inhibitors in clinical practice
· Understand how to approach biologics in the management of inflammatory bowel disease
· Recognize the difference between biologics and biosimilars
· Understand the newest treatment modalities for the irritable bowel syndrome
· Recognize the role of probiotics in the management the irritable bowel syndrome
· Provide a comprehensive approach to the management of decompensated cirrhosis
· Understand emerging therapies for hepatic encephalopathy and the hepatorenal syndrome
· Recognize the role of therapeutic endoscopic ultrasound and explore future indications
· Understand the newest treatments for hepatitis C virus
· Provide a comprehensive approach to the management of alcoholic hepatitis
· Understand the risk-benefit ratio of corticosteroid use in alcoholic hepatitis
· Recognize the different anticoagulants and antiplatelet agents and their potential impact on post-procedure bleeding
· Understand if and when it is appropriate to stop anticoagulants and/or antiplatelet agents in the peri-procedural period
· Provide a comprehensive approach to the management of functional dyspepsia
· Understand new guidelines for H. Pylori eradication
· Understand the stratified management approach to C. Difficile colitis
· Recognize the difference between recurrent C. Difficle colitis and overdiagnosis with oversensitive testing
· Obtain hands-on experience with the newest endoscopic platforms and tools